Выпуск
Pharmaceutical Executive Daily: FDA Approves Onswik
Pharmaceutical Executive · 24 сентября 2026 г. · 2 мин
InnoCare Pharma and Eli Lilly ink a multibillion-dollar research collaboration, FDA approves Lilly's once-weekly insulin Onswik for type 2 diabetes, and Jen Lamppa talks fixing clinical trial patient enrollment with real-world data.